Evaluating Patient Decisions: Dr. Schwartz's View
Peter Schwartz, MD, PhD, director of the IU Center for Bioethics and Professor of Medicine and Bioethics at IU School of Medicine, presented at Bioethics Grand Rounds last week. He focused on how to evaluate patient decision-making and the somewhat elusive measurement of decision quality.
Insulin Price Controls, Who Falls Through the Gaps?
Insulin price controls have recently emerged to contain the out of pocket cost of insulin, but not everyone is protected. This blog discusses the current
AI and Bioethics: Professor Hartsock's View
On October 24, 2024, Jane Hartsock, JD, MA, presented 'The Sky is Falling! The Ethical Implications of Artificial Intelligence and Large Language Models" as part
Who Deserves Ozempic? The Ethical Challenges of Weight-Loss Use
As the new ‘miracle drug’ for weight loss, Ozempic is one of the most popular new drugs in America, and there isn’t enough Ozempic for
Social media use by patients with hypermobile EDS
There is an enormous capacity for how social media in our current age can be utilized. In cases of chronic diseases such as Ehlers-Danlos Syndrome (EDS),
On the Increase in Use of GLP-1s
GLP-1 agonists, which include Ozempic, Mounjaro, and Wegovy, are already FDA-approved for type-2 diabetes, weight loss, and heart disease. Research shows a 40-fold increase in
The Value of the Holocaust in Medical Education
A brief summary and response to the 2024 Silvers' Annual Lecture by the same name.
Dangerous Ignorance: What Patients Don’t Understand about Pharmacogenomics
Peter Schwartz, MD, PhD., writes about the emerging importance of pharmacogenomics as well as current shortcomings in patients' understanding of pharmacogenomic testing results.
NaloxBoxes
Read all about the effects and ethics of the new NaloxBox at IUPUI, a Narcan distribution machine that's saving lives!
Doyle Publishes in Health Affairs on Personal Experience with Decision Aids
Tom Doyle, PhD, a postdoctoral fellow from the Center for Bioethics, reflects on his recent publication in Health Affairs on his personal experience with Hodgkin's